2026 NPPES data Endocrinology, Diabetes & Metabolism Physician NPI 1861954265 MD, MBA
Verify on CMS →

Dieula John, MD, MBA

Endocrinology, Diabetes & Metabolism Physician in Apopka, Florida.

This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 8,078 in Endocrinology, Diabetes & Metabolism Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.

Federal data, no proprietary rating. We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
60
Medicare Part D claims · 37 beneficiaries · Endocrinology, Diabetes & Metabolism Physician avg: 3K
Industry payments
$253.36
6 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

Dieula John, MD, MBA filed 60 Medicare Part D claims in 2024 as an Endocrinology, Diabetes & Metabolism Physician in Apopka, Florida.

60
Part D claims, 2024
Likely
board-certified (heuristic)
≥0th
pct by Part D claim volume (lower-bound band)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.

Federal trust snapshot

What official records show about Dieula John, MD, MBA

Federal records show an active NPI with Medicare Part D prescribing activity — verifiable registry data, not a proprietary rating.

  • Verified

    NPI registry status

    Active listing in the CMS National Provider Identifier Registry (NPI 1861954265), first enumerated 04/03/2019.

    Source: CMS NPPES

  • Reported

    Medicare Part D participation

    Filed 60 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.

    Source: CMS Part D Prescriber PUF

  • Reported

    Board certification signal

    Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.

    Source: NUCC taxonomy + CMS participation heuristic

  • Reported

    Hospital affiliations

    2 CMS Care Compare hospital affiliations on record — practice footprint from the Doctors and Clinicians file.

    Source: CMS Care Compare

  • Reported

    Industry payment transparency

    $253.36 in reported industry payments (6 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.

    Source: CMS Open Payments

  • State context

    State board disciplinary context

    Florida statewide board action statistics are published annually — these figures describe aggregate state activity, not Dieula John, MD, MBA's individual license status. Verify directly with the state medical board.

    Source: FLDOH annual report 2023

  • Not in federal data

    Individual sanction lookup

    PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.

    Source: State medical board / FSMB

This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.

CMS NPPES provider registry desk

NPI 1861954265 · Endocrinology, Diabetes & Metabolism Physician

NPI-10 · ENUM-RECENT · TAX-MID · RX-TRACE · BOOK-LIGHT · PHOTO-ENUM

  • NPI-10 1861954265
  • ENUM-RECENT 2019
  • TAX-MID 8K Endocrinology, Diabetes
  • RX-TRACE 60
  • BOOK-LIGHT 538 in Florida
  • PHOTO-ENUM Jordesha Hodge · 2019

Dieula John, MD, MBA's Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2024, across all CMS prescribers nationally

60 ≥ 0th percentile 0% of 1,416,883 prescribers are in lower value bands

0–200: 679,947 prescribers (48%). This entry sits in this band. 200–400: 188,835 prescribers (13%). Above this entry. 400–600: 95,866 prescribers (7%). Above this entry. 600–800: 60,107 prescribers (4%). Above this entry. 800–1,000: 43,043 prescribers (3%). Above this entry. 1,000–1,200: 33,612 prescribers (2%). Above this entry. 1,200–1,400: 27,889 prescribers (2%). Above this entry. 1,400–1,600: 23,183 prescribers (2%). Above this entry. 1,600–1,800: 19,917 prescribers (1%). Above this entry. 1,800–2,000: 17,585 prescribers (1%). Above this entry. 2K+: 226,899 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

The percentile is a conservative 100-claim band: it counts only prescribers in lower claim-volume bands. Medicare Part D claim volume is activity context, not a quality measure or recommendation. See methodology § corpus placement.

Source CMS Medicare Part D Prescriber Public Use File · 2024

Board certification likely (heuristic, not verified)

Dieula John, MD, MBA practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 2 hospital affiliations - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about Dieula John, MD, MBA?

Quality data not reported

NPI registry status

Active

Issued 04/03/2019

NPI 1861954265

Primary specialty

Endocrinology, Diabetes & Metabolism Physician

Mid-sized

8,078 US NPIs in this specialty

Medicare Part D claims

60 98% vs specialty avg

2024 prescription claims

Specialty avg: 2,739

Specialty distribution in Florida

How Endocrinology, Diabetes & Metabolism Physician compares to other specialties among Florida providers

Florida providers
Behavior Technician16.3%Mental Health Counselor4.8%Family Nurse Practitioner4.5%Pharmacist4.1%Student in an Organized Heal…4.1%Physical Therapist3%Endocrinology, Diabetes & Me…0.1%
Largest specialties in Florida (% of in-state providers)

Board certification

Not published by CMS

CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Endocrinology, Diabetes & Metabolism Physician. Verify directly:

How MIPS and board certification work

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

Practice Address

201 N PARK AVE STE 303
Apopka, FL 32703

Provider Details

NPI 1861954265
Specialty Endocrinology, Diabetes & Metabolism Physician
Credentials MD, MBA
Gender Female
NPI Issued 04/03/2019

Hospital and facility affiliations

Facilities where Dieula John, MD, MBA bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

Central Florida Inpatient Medicine LLC
Lake Mary, FL
Florida Hospital Medical Group Inc
Apopka, FL

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) - CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Dieula John, MD, MBA. Source: openpaymentsdata.cms.gov.

Total received

$253

Largest payer

Amgen Inc.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context - Florida FLDOH 2023 annual report

Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~75K Florida medical licensees in 2023 - they are NOT specific to Dieula John, MD, MBA. To verify Dieula John, MD, MBA's current license status, search the FLDOH public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

480
Total board actions, Florida 2023
Across 467 cases
6.40
Actions per 1,000 licensees
Florida statewide rate
monetary fine
Most common action type
138 cases

FLDOH publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Florida disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2024.

60
Total Claims
$16K
Total Drug Cost
37
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
85.9
Total Day Supply
2,089
Generic Drug Cost
$305

Patient Demographics

Average Patient Age
72.4 years
Avg HCC Risk Score
2.11
Gender Split
62% female / 38% male

Endocrinology, Diabetes & Metabolism Physician Overview

How Dieula John, MD, MBA fits within the Endocrinology, Diabetes & Metabolism Physician landscape nationally.

8,078
Endocrinology, Diabetes & Metabolism Physician Providers in US
54
States with Endocrinology, Diabetes & Metabolism Physician
2,739
Avg Claims per Provider

Dieula John, MD, MBA's 60 claims are below the specialty average of 2,739.

Nationwide Endocrinology, Diabetes & Metabolism Physician peers with similar MIPS or enrollment year

Two federal-record peer sets for John, both outside Florida so the neighborhoods are not geographic containment.

Same NPPES enumeration year (2019)

Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.

Nearby Endocrinology, Diabetes & Metabolism Physician Providers in Florida

Other clinicians with the same primary specialty enrolled in Florida, drawn from the same CMS NPPES roster as John.

One of 538 Endocrinology, Diabetes & Metabolism Physician providers enrolled in Florida, 5 are shown here.

Compare Endocrinology, Diabetes & Metabolism Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is Dieula John, MD, MBA's specialty?
Dieula John, MD, MBA specializes in Endocrinology, Diabetes & Metabolism Physician and practices in Apopka, Florida. Credentials: MD, MBA.
How much does Dieula John, MD, MBA prescribe under Medicare Part D?
In 2024, Dieula John, MD, MBA wrote 60 Medicare Part D claims totaling $16K in drug costs for 37 beneficiaries.
Where is Dieula John, MD, MBA located?
Dieula John, MD, MBA is located at 201 N PARK AVE STE 303, Apopka, FL, 32703. Phone: (407) 329-4992.
What is Dieula John, MD, MBA's NPI number?
Dieula John, MD, MBA's National Provider Identifier (NPI) is 1861954265, issued on 04/03/2019.
How many Endocrinology, Diabetes & Metabolism Physician providers are there in the US?
There are 8,078 Endocrinology, Diabetes & Metabolism Physician providers across 54 states in the US. The average Endocrinology, Diabetes & Metabolism Physician provider writes 2,739 Medicare Part D claims per year.
Does Dieula John, MD, MBA accept Medicare?
Dieula John, MD, MBA appears in CMS Medicare data with 60 Part D claims and 37 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Dieula John, MD, MBA's credentials?
Dieula John, MD, MBA's NPI is 1861954265 with credentials MD, MBA. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

View source datasets and methodology notes
Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology

Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.